Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Health Catalyst Inc shares valued at $21,331 were sold by LeSueur Daniel on May 05 ’25. At $4.10 per share, LeSueur Daniel sold 5,209 shares. The insider’s holdings dropped to 205,832 shares worth approximately $0.77 million following the completion of this transaction.
Also, LeSueur Daniel sold 5,209 shares, netting a total of over 21,604 in proceeds. Following the sale of shares at $4.15 each, the insider now holds 211,041 shares.
Before that, DANIEL LESUEUR had added 10,418 shares to its account. In a trade valued at $46,360, the Officer bought Health Catalyst Inc shares for $4.45 each.
As published in a research note from Evercore ISI on April 09, 2025, Health Catalyst Inc [HCAT] has been rated down from an Outperform to an In-line. Analysts at KeyBanc Capital Markets upgraded the stock from ‘”a Sector weight”‘ to ‘”an Overweight”‘ outlook in a report released in early January. As of April 10, 2024, KeyBanc Capital Markets has decreased its “an Overweight” rating to a “Sector weight” for HCAT. Earlier on January 03, 2024, Evercore ISI upgraded its rating. Their new recommendation was “an Outperform” for HCAT stock which previously was a “an In-line”.
Analyzing HCAT Stock Performance
Over the course of the year, Health Catalyst Inc shares have dropped approximately -47.10%. Shares of the company reached a 52-week high of $7.65 on 01/06/25 and a 52-week low of $3.49 on 05/29/25.
Support And Resistance Levels for Health Catalyst Inc (HCAT)
According to the 24-hour chart, there is a support level at 3.56, which, if violated, would cause prices to drop to 3.37. In the upper region, resistance lies at 3.86. The next price resistance is at 3.97. RSI (Relative Strength Index) is 42.51 on the 14-day chart, showing neutral technical sentiment.
